- MBNMAdose::alog_pcfbStudies of alogliptin for lowering blood glucose concentration in patients with type II diabetes
- MBNMAdose::goutStudies of treatments for Serum Uric Acid reduction in patients with gout
- MBNMAdose::osteopainStudies of treatments for pain relief in patients with osteoarthritis
- MBNMAdose::psoriasis100Studies of biologics for treatment of moderate-to-severe psoriasis (100% improvement)
- MBNMAdose::psoriasis75Studies of biologics for treatment of moderate-to-severe psoriasis (>=75% improvement)
- MBNMAdose::psoriasis90Studies of biologics for treatment of moderate-to-severe psoriasis (>=90% improvement)
- MBNMAdose::ssi_closureStudies of wound closure methods to reduce Surgical Site Infections (SSI)
- MBNMAdose::ssriStudies of Selective Serotonin Reuptake Inhibitors (SSRIs) for major depression
- MBNMAdose::triptansStudies of triptans for headache pain relief
- MBNMAtime::alog_pcfbStudies of alogliptin for lowering blood glucose concentration in patients with type II diabetes
- MBNMAtime::copdStudies comparing Tiotropium, Aclidinium and Placebo for maintenance treatment of moderate to severe chronic obstructive pulmonary disease
- MBNMAtime::diabetesStudies comparing treatments for type 2 diabetes
- MBNMAtime::goutSUA_CFBStudies of treatments for reducing serum uric acid in patients with gout
- MBNMAtime::goutSUA_CFBcombStudies of combined treatments for reducing serum uric acid in patients with gout
- MBNMAtime::hyalarthritisStudies comparing hyaluronan (HA)–based viscosupplements for osteoarthritis
- MBNMAtime::obesityBW_CFBStudies of treatments for reducing body weight in patients with obesity
- MBNMAtime::osteopainStudies of pain relief medications for osteoarthritis